386 related articles for article (PubMed ID: 17351373)
21. Differential alterations in sympathetic neurotransmission in mesenteric arteries and veins in DOCA-salt hypertensive rats.
Luo M; Hess MC; Fink GD; Olson LK; Rogers J; Kreulen DL; Dai X; Galligan JJ
Auton Neurosci; 2003 Feb; 104(1):47-57. PubMed ID: 12559203
[TBL] [Abstract][Full Text] [Related]
22. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension.
Ni W; Fink GD; Watts SW
J Pharmacol Exp Ther; 2007 May; 321(2):485-91. PubMed ID: 17289838
[TBL] [Abstract][Full Text] [Related]
23. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
[TBL] [Abstract][Full Text] [Related]
24. Altered vascular reactivity and KATP channel currents in vascular smooth muscle cells from deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Ghosh M; Hanna ST; Wang R; McNeill JR
J Cardiovasc Pharmacol; 2004 Nov; 44(5):525-31. PubMed ID: 15505488
[TBL] [Abstract][Full Text] [Related]
25. Cilostazol suppresses angiotensin II-induced vasoconstriction via protein kinase A-mediated phosphorylation of the transient receptor potential canonical 6 channel.
Nishioka K; Nishida M; Ariyoshi M; Jian Z; Saiki S; Hirano M; Nakaya M; Sato Y; Kita S; Iwamoto T; Hirano K; Inoue R; Kurose H
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2278-86. PubMed ID: 21799177
[TBL] [Abstract][Full Text] [Related]
26. Gender differences in vascular expression of endothelin and ET(A)/ET(B) receptors, but not in calcium handling mechanisms, in deoxycorticosterone acetate-salt hypertension.
David FL; Montezano AC; Rebouças NA; Nigro D; Fortes ZB; Carvalho MH; Tostes RC
Braz J Med Biol Res; 2002 Sep; 35(9):1061-8. PubMed ID: 12219177
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of Na+ and Ca2+ transporters in arterial smooth muscle from ouabain-induced hypertensive rats.
Pulina MV; Zulian A; Berra-Romani R; Beskina O; Mazzocco-Spezzia A; Baryshnikov SG; Papparella I; Hamlyn JM; Blaustein MP; Golovina VA
Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H263-74. PubMed ID: 19897708
[TBL] [Abstract][Full Text] [Related]
28. PI3-kinase upregulation and involvement in spontaneous tone in arteries from DOCA-salt rats: is p110delta the culprit?
Northcott CA; Hayflick JS; Watts SW
Hypertension; 2004 Apr; 43(4):885-90. PubMed ID: 14993194
[TBL] [Abstract][Full Text] [Related]
29. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chen CC; Chang NC
Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
[TBL] [Abstract][Full Text] [Related]
30. Antioxidant treatment restores prejunctional regulation of purinergic transmission in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats.
Demel SL; Dong H; Swain GM; Wang X; Kreulen DL; Galligan JJ
Neuroscience; 2010 Jun; 168(2):335-45. PubMed ID: 20398741
[TBL] [Abstract][Full Text] [Related]
31. p38 mitogen-activated protein kinase contributes to the diminished aortic contraction by endothelin-1 in DOCA-salt hypertensive rats.
Kim B; Kim J; Bae YM; Cho SI; Kwon SC; Jung JY; Park JC; Ahn HY
Hypertension; 2004 May; 43(5):1086-91. PubMed ID: 15051668
[TBL] [Abstract][Full Text] [Related]
32. Vascular responses to serotonin in steroid hypertensive rats.
Mecca TE; Webb RC
Hypertension; 1984; 6(6 Pt 1):887-92. PubMed ID: 6519745
[TBL] [Abstract][Full Text] [Related]
33. Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats.
Molero MM; Giulumian AD; Reddy VB; Ludwig LM; Pollock JS; Pollock DM; Rusch NJ; Fuchs LC
J Hypertens; 2002 Sep; 20(9):1799-805. PubMed ID: 12195122
[TBL] [Abstract][Full Text] [Related]
34. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.
David FL; Carvalho MH; Cobra AL; Nigro D; Fortes ZB; Rebouças NA; Tostes RC
Hypertension; 2001 Sep; 38(3 Pt 2):692-6. PubMed ID: 11566958
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone acetate-salt hypertension.
Banes AK; Watts SW
Hypertension; 2002 Feb; 39(2 Pt 2):394-8. PubMed ID: 11882579
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity of caudal arteries and the mesenteric vascular bed to norepinephrine in DOCA-salt hypertension.
Longhurst PA; Rice PJ; Taylor DA; Fleming WW
Hypertension; 1988 Aug; 12(2):133-42. PubMed ID: 3410523
[TBL] [Abstract][Full Text] [Related]
37. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
Watts SW; Fink GD
Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
[TBL] [Abstract][Full Text] [Related]
38. Role of endogenous TRPC6 channels in Ca2+ signal generation in A7r5 smooth muscle cells.
Soboloff J; Spassova M; Xu W; He LP; Cuesta N; Gill DL
J Biol Chem; 2005 Dec; 280(48):39786-94. PubMed ID: 16204251
[TBL] [Abstract][Full Text] [Related]
39. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats.
Intengan HD; He G; Schiffrin EL
Hypertension; 1998 Oct; 32(4):770-7. PubMed ID: 9774378
[TBL] [Abstract][Full Text] [Related]
40. The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension.
Watts SW
J Hypertens; 1998 Jun; 16(6):811-22. PubMed ID: 9663921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
